Advanced search
Publication Cover
International Journal of Neuroscience Volume 128, 2018 - Issue 12
Submit an article Journal homepage
135
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Uric acid level may not be reduced in essential tremor

Chae Young LeeDepartment of Neurology Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea; View further author information
,
Jung Han YoonDepartment of Neurology, Ajou University School of Medicine, Suwon, Republic of Korea; View further author information
,
Jeong-Ho ParkDepartment of Neurology, College of Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Republic of Korea; View further author information
,
Jin Yong HongDepartment of Neurology, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea; View further author information
,
Mun Kyung SunwooDepartment of Neurology, Bundang Jesaeng General Hospital, Seongnam, Republic of KoreaView further author information
&
Suk Yun KangDepartment of Neurology Dongtan Sacred Heart Hospital, Hallym University College of Medicine, Hwaseong, Republic of Korea; Correspondence[email protected]
View further author information
Pages 1163-1167 | Received 25 Jan 2018, Accepted 17 Jun 2018, Published online: 20 Aug 2018

References

  • Espay AJ, Lang AE, Erro R, et al. Essential pitfalls in “essential” tremor. Mov Disord. 2017;32:325–331.
  • Deuschl G, Elble R. Essential tremor–neurodegenerative or nondegenerative disease towards a working definition of ET. Mov Disord. 2009;24:2033–2041.
  • Shill HA, Adler CH, Sabbagh MN, et al. Pathologic findings in prospectively ascertained essential tremor subjects. Neurology. 2008;70:1452–1455.
  • Abraham A, Drory VE. Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis. J Neurol. 2014;261:1133–1138.
  • Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443:787–795.
  • Kanbay M, Jensen T, Solak Y, et al. Uric acid in metabolic syndrome: from an innocent bystander to a central player. Eur J Intern Med. 2016;29:3–8.
  • Lima WG, Martins-Santos ME, Chaves VE. Uric acid as a modulator of glucose and lipid metabolism. Biochimie. 2015;116:17–23.
  • Martin MG, Pfrieger F, Dotti CG. Cholesterol in brain disease: sometimes determinant and frequently implicated. EMBO Rep. 2014;15:1036–1052.
  • Hu G, Antikainen R, Jousilahti P, et al. Total cholesterol and the risk of Parkinson disease. Neurology. 2008;70:1972–1979.
  • Lesser GT, Haroutunian V, Purohit DP, et al. Serum lipids are related to Alzheimer’s pathology in nursing home residents. Dement Geriatr Cogn Disord. 2009;27:42–49.
  • Dupuis L, Corcia P, Fergani A, et al. Dyslipidemia is a protective factor in amyotrophic lateral sclerosis. Neurology. 2008;70:1004–1009.
  • Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc Scientific Committee. Mov Disord. 1998;13(Suppl 3):2–23.
  • Elble R, Comella C, Fahn S, et al. Reliability of a new scale for essential tremor. Mov Disord. 2012;27:1567–1569.
  • Chen X, Burdett TC, Desjardins CA, et al. Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration. Proc Natl Acad Sci USA. 2013;110:300–305.
  • Wen M, Zhou B, Chen YH, et al. Serum uric acid levels in patients with Parkinson’s disease: a meta-analysis. PLoS One. 2017;12:e0173731.
  • Paganoni S, Schwarzschild MA. Urate as a marker of risk and progression of neurodegenerative disease. Neurotherapeutics. 2017;14:148–153.
  • Sampat R, Young S, Rosen A, et al. Potential mechanisms for low uric acid in Parkinson disease. J Neural Transm (Vienna). 2016;123:365–370.
  • Du N, Xu D, Hou X, et al. Inverse association between serum uric acid levels and Alzheimer’s disease risk. Mol Neurobiol. 2016;53:2594–2599.
  • Ye BS, Lee WW, Ham JH, et al. Does serum uric acid act as a modulator of cerebrospinal fluid Alzheimer’s disease biomarker related cognitive decline? Eur J Neurol. 2016;23:948–957.
  • Lu N, Dubreuil M, Zhang Y, et al. Gout and the risk of Alzheimer’s disease: a population-based, BMI-matched cohort study. Ann Rheum Dis. 2016;75:547–551.
  • Kuzuya M, Ando F, Iguchi A, et al. Effect of aging on serum uric acid levels: longitudinal changes in a large Japanese population group. J Gerontol A Biol Sci Med Sci. 2002;57:M660–M664.
  • de Oliveira FF, Chen ES, Smith MC, et al. Longitudinal lipid profile variations and clinical change in Alzheimer’s disease dementia. Neurosci Lett. 2017;646:36–42.
  • Huang X, Alonso A, Guo X, et al. Statins, plasma cholesterol, and risk of Parkinson’s disease: a prospective study. Mov Disord. 2015;30:552–559.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.